mchsideris

[Néha Sihra @nehasihra]

Proud to be part of the team @NHSBartsHealth @Barts_Charity @lambwben @2frcsurol @MezAref @guy_worley @mchsideris

https://t.co/xfFgMolo2z

[Prof Ranjit Manchanda @ProfManchanda]

Delighted our paper- Sys review of QOL outcomes after preventive hysterectomy- is out today in Cancers. Congrats Sam Oxley & rest of the team. Thx stakeholders & funders. @RosetreesT @yorkshirecancer @eveappeal @QMUL_WIPH @QMUL_WIPH_CPDD @LynchSyndromeUK https://t.co/7xgtDofYib

[Prof Ranjit Manchanda @ProfManchanda]

https://t.co/FxWCycbjgt Great to see our paper/commentary on Pop Genetic Testing out. @yorkshirecancer @NHSAccelerator @eveappeal @Barts_Charity @RosetreesT @EngageEsgo @ENYGO_official @QMBCI @QMUL_WIPH @BJOGTweets @RCObsGyn @NHSBartsHealth @GOGirls2015 @BRCAUmbrella

[Prof Ranjit Manchanda @ProfManchanda]

Delighted to win the Ovacure Competition in Copenhagen today. Thx ⁦@OvaCure_COCT⁩ for the seed funding for new trials & collaborations. #ovacatch team - Steve skates, ⁦@Prof_UMenon⁩ , Estrid Hogdall, Winnie Svendsen, Karin Sundfeldt ⁦@QMUL⁩ ⁦@QMBCI⁩ ⁦

[Prof Ranjit Manchanda @ProfManchanda]

Delighted to speak at and chair the session on screening and prevention BGCS2022. Great talks by all speakers - @ProfEmmaCrosbie @Prof_UMenon Prof Jack Cuzick @BGCS_org @QMUL_WIPH_CPDD @QMUL_WIPH @MRCCTU @NHSBartsHealth

[Prof Ranjit Manchanda @ProfManchanda]

Great short presentations at BGCS. Well done Ashwin Kalra - presenting on cost effectiveness of panel germline testing in ovarian cancer @BGCS_org @BgcsFellows @QMUL_WIPH_CPDD @QMUL_WIPH @NHSBartsHealth

[Prof Ranjit Manchanda @ProfManchanda]

Congratulations to Xia Wei presenting her PHD work on meta analysis of QOL outcomes following risk reducing surgery RRM/RRSO/RRESDO in BRCA carriers at bgcs 2020. @BGCS_org @QMUL_WIPH_CPDD @QMUL_WIPH @LSHTM @RosetreesT @Barts_Charity

[Prof Ranjit Manchanda @ProfManchanda]

Delighted to receive grant from @yorkshirecancer for #PROTECT trial - research into population genetic testing for cancer susceptibility genes in the UK. Looking forward to working with colleagues, collaborators, partners, stakeholders. https://t.co/59Yd4bcV6h

[Prof Ranjit Manchanda @ProfManchanda]

https://t.co/wcFMaTtlmE Delighted to see our paper on Population genetic testing for ovarian cancer risk prediction out in Diagnostics. Qualitative data supporting our earlier quantitative analysis. Moving the needle forward in the direction of pop testing. More work to follow.

[mchsideris @mchsideris]

@ProfManchanda ENGAGE patients information sheet on genetic testing in gynae cancers
https://t.co/bIW88VMmqm

[Prof Ranjit Manchanda @ProfManchanda]

Our advert for a Clinical Research Fellow to join our clinical academic research team is open for another week. Suitable for those interested in research in gynae oncology. https://t.co/907GYsQB3J https://t.co/XqfZN8o678 @NHSBartsHealth @QMUL_WIPH_CPDD @QMULBartsTheLon

[Prof Ranjit Manchanda @ProfManchanda]

Our advert for a Clinical Research Fellow to join our clinical academic team in gynae oncology is out. There is significant protected academic time. @QMBCI @QMUL_WIPH_CPDD @NHSBartsHealth @BGCS_org @BgcsFellows https://t.co/PC2a7hGXMP

[mchsideris @mchsideris]

https://t.co/F3LSBEAvuk

[mchsideris @mchsideris]

https://t.co/m8LFFSvMqY

[Int. Society of Pelvic Surgery @surgerypelvis]

New study by @mchsideris "screening for KRAS mutations in patients with hyperplastic endometrium or early-stage type I EC, may provide important information for prognosis stratification, and further provision of personalised treatment options."
https://t.co/e9hQz8L2Ix

[Simi Bansal @simi_bansal]

Best start to a lecture I've ever seen! Why do we still hide behind lecterns in lectures? #Woozletracks @kt_network

[mchsideris @mchsideris]

#woozletracks power of network

[mchsideris @mchsideris]

#woozletracks

[mchsideris @mchsideris]

#woozletracks find ur mentors

[mchsideris @mchsideris]

#woozletracks its all about a journey